Hepatitis C has become so widespread that experts are calling on doctors to screen all adults 18 to 79, even those with no known risk factors or symptoms.
“Exotendon,” a device that is clipped between a runner’s shoes and links them together, may be the secret to running faster.
Stanford researcher Eleni Linos turned to social media to see if it was a more effective way to spread information about skin cancer and tanning to youth.
In this installment of "Aspirin for prevention," physician-researcher Randall Stafford provides tips to calculate the risk of heart disease or stroke, to inform decisions about taking aspirin preventatively.
A team of Stanford physicians explains why research has found that taking aspirin to prevent cardiovascular disease may be riskier than previously thought.
Many metastatic colorectal cancers appear "born to be bad," spreading to other organs before any diagnosis has been made, say Stanford researchers.
Stanford geneticists discuss the future of genomics, including the importance of studying diverse populations for medical research.
A push to personalize medicine can backfire when it comes to screening for colorectal cancer, says a Stanford gastroenterologist.
Stanford psychologist Ian Gotlib is examining how depression develops and working to identify potential opportunities for intervention.
Decision scientist Mehlika Toy is working with the WHO to help eliminate the public health burden of hepatitis B by the year 2030.
The U.S. Preventive Services Task Force is now recommending that men aged 55 to 69 should talk with their doctors about prostate-specific antigen screening.
Do you sigh for cinnamon rolls, pine for pastries, or lust after lemon meringue pie? You aren’t alone, and Stanford Medicine wants to help. But …